ClinicaliQ Trial Snapshot
- Breast Cancer BRAs Study (Breast Cancer Biomechanics of Radiotherapy And Surgery) — Recruiting • Oncology • NCT07135960.
- What is being tested: The study evaluates whether breast biomechanics can be reliably measured and assessed in women who have undergone breast cancer treatment (radiotherapy and/or surgery), potentially establishing new biomarkers for treatment outcomes.
- Patient eligibility overview: The trial recruits women with a history of breast cancer who have received radiotherapy and/or surgical intervention, allowing researchers to compare biomechanical changes across different treatment modalities and recovery timepoints.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This study, delivered by Portsmouth Hospitals University NHS Trust in conjunction with the Research Group in Breast Health at the University of Portsmouth [1], aims to assess whether it is possible to test breast biomechanics in women who have had surgery with or without radiotherapy for the treatment of breast cancer.
Eligibility Snapshot
- : * Female * 18 years of age or above * Early or locally advanced breast cancer classified as B5a or B5b (radical treatment intent) * Unilateral breast cancer (contralateral breast used as control) * Receiving or has received breast cancer surgery * +/- Adjuvant radiotherapy * Able to travel to the University of Portsmouth Breast biomechanics laboratory * Participant has capacity to consent.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.